Drug Development
AI-native therapeutic design — from target to validated lead. Propose, score and de-risk candidate molecules with the same cited, auditable rigor that Quill brings to constructs.
Products
Telesphorus builds AI-native design intelligence for biology — tools that propose and validate, not just draw. Quill is live today; two more programs are on the way.
Describe a construct in plain English — Quill plans the build, fetches real biological data, designs and validates it, screens it for biosecurity, and returns synthesis-ready output with a GO / CONDITIONAL / NO-GO verdict.
On the roadmap
Same principles — AI that proposes and validates, every decision cited, depth in a niche over breadth. Both are early-stage and not yet available — they can't be requested or inquired about right now. The free pilot is for Quill only.
AI-native therapeutic design — from target to validated lead. Propose, score and de-risk candidate molecules with the same cited, auditable rigor that Quill brings to constructs.
Neuropharmacogenomic screening for the brain — model CNS drug exposure and response so the right therapy reaches the right patient. A vertical bet: depth in neuro beats breadth.
AI explains and orchestrates; deterministic engines are the source of truth. Every number traces to an engine output or a citation.
A first-class biosecurity gate on every design and every generated candidate — never silently skipped, never auto-overridden.
Outputs open directly in the tools you already use. We attack lock-in and opaque pricing — so we won't become it.
Free pilot · open
Work directly with the founder and put Quill — our live product — to work on your bench, at no cost. (Drug Development and CNS Screening are still in development and not yet open.)